Combinatorial Therapies in Melanoma: MAPK Inhibitors and Beyond. [electronic resource]
Producer: 20180907Description: 181-193 p. digitalISSN:- 1179-1888
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- CTLA-4 Antigen -- antagonists & inhibitors
- Disease-Free Survival
- Humans
- Immunologic Surveillance -- drug effects
- Immunotherapy -- methods
- MAP Kinase Signaling System -- drug effects
- Melanoma -- drug therapy
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Molecular Targeted Therapy -- methods
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Skin Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.